I want to thank the panel for coming and appearing before the committee today.
My first question is for Mr. Jim Keon.
According to the Patented Medicine Prices Review Board, PMPRB, generic drug prices in Canada fell by 45% between 2010 and 2014. They continue to remain 19% higher than the international average. Why does Canada continue to have higher generic drug prices than other jurisdictions?